Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds
Global News
The three-year study of tirzepatide found adults with prediabetes and obesity or overweight taking the drug weekly saw the risk of progression to diabetes lower by 94 per cent.
The drug tirzepatide, made popular for its treatment of Type 2 diabetes and weight loss, lowers the risk of progression to diabetes by 94 per cent among adults with prediabetes and obesity or who are overweight when taken weekly, according to a new study by the drugmaker Eli Lilly.
While the study has not yet been peer-reviewed, experts who spoke with Global News for their views on its findings said the data so far suggests the possibility of risk reduction over the course of years to come.
Results of the three-year study of the drug, also known by its brand names Mounjaro and Zepbound, were released on Tuesday with the report showing weekly injections of any of the three dosage amounts — five, 10 and 15 milligrams — “significantly reduced” the risk of progression, and also saw sustained weight loss.
In fact, those on the 15 mg dose also saw a 22.9 per cent average decrease in body weight compared with just 2.1 per cent among those who took a placebo during the study’s treatment period.
“It is highly significant that this study showed that in those people who had prediabetes,” Dr. Caroline Apovine, co-director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital in Boston, told Global News. “That is a major risk reduction in development of Type 2 diabetes.”
Apovine had no involvement in the study nor with Eli Lilly.
Mounjaro, which has also been approved for use in Canada, is used primarily for diabetes treatment but like its sibling Zepbound has also been approved for weight-loss use.
Zepbound was approved in the U.S. last year for people considered obese, with a body mass index of 30 or higher, and those who are overweight with a related health condition, like high blood pressure or diabetes. The Food and Drug Administration said the drug should be paired with a healthy diet and regular exercise.
Some experts say that a cyberwar through 'proxies' may be the next stage of the Iran war, with civilian infrastructure also coming under threat.
The study is being billed by the university as "the first to study a wide range of factors which link ADHD symptoms and mental ill health symptoms over time."
The group says MAGA Energy hasn't paid its lease for three years, and therefore the company is no longer allowed on their land in Edmonton.
The analysis by the Canadian Climate Institute says oilsands producers will pay an average of about 50 cents per oil barrel, if the minimum carbon price rises to $130 per tonne.
Between November 29 and February 27, authorities recorded 406 outbreaks of bird flu in domestic birds in 32 European countries and 2,108 outbreaks in wild birds, they said.
Dr. Michael Domeier, director of the Marine Conservation Science Institute, told Global News that they tag the adult females as they are the most interesting.
Regina’s recycling contamination is currently triple the limit and city is urging resident to change sorting habits now to avoid citywide fines and higher resident fees.
The study found that higher ultra-processed food intake at age three years was associated with adverse behavioural and emotional symptoms at age five years.
Edmonton's single-use waste rules were controversial and unpopular when introduced in 2023 — but new data shows the changes are having the intended effect of reducing garbage.
Carney's speech to Australia's parliament highlighted a soon-to-launch Canadian low earth orbit satellite network that experts say could soon compete with Elon Musk's Starlink.
The Pentagon said in a statement Thursday that it has “officially informed Anthropic leadership the company and its products are deemed a supply chain risk, effective immediately.”
Opioid overdose deaths in Canada are falling, but there's growing concerns on a certain veterinary tranquilizer being cut into fentanyl and other opioids.
The product is being recalled in Alberta, British Columbia, Manitoba, Ontario, Quebec and Saskatchewan due to 'undeclared almonds' being found.